Digitalis Ventures
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- Biotechnology
- AI
- Health Tech
- Blockchain
About
Digitalis Ventures is a forward-thinking venture capital firm dedicated to engineering innovative solutions for the most pressing unmet needs in the healthcare sector. Leveraging extensive technical, financial, and industry-specific expertise, the firm actively invests in groundbreaking technologies and startups that have the potential to transform patient care and improve health outcomes. With a commitment to aligning investment strategies with public interest, Digitalis Ventures fosters collaboration between visionary entrepreneurs and leading experts to accelerate the development of meaningful healthcare solutions. Through its strategic approach, the company not only drives financial returns but also contributes to the advancement of healthcare innovation on a global scale.
Digitalis Ventures is a forward-thinking venture capital firm dedicated to engineering innovative solutions for the most pressing unmet needs in the healthcare sector. Leveraging extensive technical, financial, and industry-specific expertise, the firm actively invests in groundbreaking technologies and startups that have the potential to transform patient care and improve health outcomes. With a commitment to aligning investment strategies with public interest, Digitalis Ventures fosters collaboration between visionary entrepreneurs and leading experts to accelerate the development of meaningful healthcare solutions. Through its strategic approach, the company not only drives financial returns but also contributes to the advancement of healthcare innovation on a global scale.
Investment Thesis
Digitalis Ventures focuses on investing in early to growthstage companies that are developing innovative solutions in healthcare, life sciences, and food systems. Their investment thesis is centered on supporting businesses that leverage science, technology, and data to improve human and animal health. They seek companies with strong leadership, scalable business models, and the potential for longterm impact.